TLDR Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.
The study demonstrated that the enzyme 5α-reductase type 1 (5αR1) was necessary for the prepulse inhibition (PPI) deficits induced by D1 dopamine receptor activation in mice. Knockout mice lacking 5αR1 were resistant to these deficits, which were restored by administering allopregnanolone (AP), but not other 5α-reduced steroids. The PPI-disrupting effects of the D1 receptor agonist were not influenced by GABA-A or PXR receptors, indicating that 5αR1 facilitates the negative impact of D1 receptor activation on information processing through the production of AP, independent of these receptors.
Cited in this study
8 / 8 results
10 citations
,
March 2019 in “Neuropharmacology” Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.
14 citations
,
May 2018 in “Psychoneuroendocrinology” Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.
25 citations
,
June 2017 in “Scientific reports” Stress worsens Tourette symptoms by increasing allopregnanolone levels.
46 citations
,
September 2011 in “Movement Disorders” Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.
72 citations
,
January 2011 in “Current Pharmaceutical Design” S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.
17 citations
,
May 2008 in “Pharmacopsychiatry” Finasteride improved symptoms in a schizophrenia patient.
42 citations
,
December 2007 in “American Journal of Psychiatry” Finasteride may effectively reduce Tourette's syndrome symptoms and improve life quality.
83 citations
,
April 1992 in “Journal of Biological Chemistry” Four-amino acid part makes enzyme sensitive to finasteride.
